• Last Updated 15:22:57 May 03, 2016

MENU

KEY DRIVERS

Total Revenue$14 B
R&D/Sales16.7%
Operating Margin4.4%
Debt/Free Cash Flow9.5
OPERATING SALES
GEOGRAPHIC SALES

Trading Metrics

50-Day Moving Average $31.03
200-Day Moving Average $32.30
Average Daily Volume (30-Day) 56.5 M
Market Beta 0.84
Year-to-Date Price Change 1.6%
1-Year Price Change -4.4%
Short Interest 2%
Days to Cover 2.7

Metrics

Drugs Portfolio202
Pipeline Projects93
Therapeutic Areas39
Prevnar$1.25 B
Lyrica$687 B
Pristiq$154 B

DEBT & Liquidity

$39 B Total Debt

$3.64 B Total Cash

60% Debt/Equity

23.3% Debt/Assets

Summary

PFE

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative... +

235 East 42nd Street
New York New York, US

Website | Map

CEO

Ian C. Read

Founded in

1849

Employees

97,900

Revenue/Employee

$0.50 m

IPO Date

June 22, 1942

Fiscal Year Ends

FY16 - Dec 31, 2016

Sector

Healthcare

Industry

Pharmaceuticals

QUARTERLY
Revenue$14 B
Revenue Growth0
EPS$0.1
EPS Growth-50%
ANNUAL
Revenue$48.9 B
Revenue Growth0
EPS$1.11
EPS Growth-21.5%

1.49 Current Ratio

0.12 Cash Ratio

0.36% ROAA

0.93% ROAE

4.04% Operating Margin

75.7% Gross Margin

4.38% Net Income Margin

-50% EPS Growth

Dividends & Splits

$0.28 Dividend Per Share

3.66% Dividend Yield

100.6% Payout Ratio

2015-11-04 Ex-Dividend Date

VALUATION PEERS

PFE

+2.9% Change

26.5 P/E

4.1 P/S

3.1 P/Book

AGN

-1.0% Change

NA P/E

NA P/S

NA P/Book

MRK

-0.4% Change

NA P/E

NA P/S

NA P/Book

JNJ

-0.2% Change

NA P/E

NA P/S

NA P/Book

OUR DATA PARTNERS

  • MARKET DATA PROVIDED BY

  • FUNDAMENTALS AND METRICS COMPILED BY

  • CHARTING APIs PROVIDED BY

  • EARNINGS ESTIMATES VIA